Alkermes Corporate Giving

Alkermes underscores its commitment to central nervous system (CNS) disorders, such as schizophrenia, depression and addiction, by supporting educational, healthcare-related, and public policy events through sponsorships, charitable and educational grants programs, as well as through investigator initiated trials. In addition, Alkermes fosters and maintains collaborative relationships with health-related and public policy organizations through corporate memberships.